Ballast Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
21,893
+1,500
| +7% | +$104K | 0.45% | 35 |
|
|
2025
Q1 | $1.42M | Buy |
20,393
+1,938
| +11% | +$135K | 0.45% | 34 |
|
|
2024
Q4 | $1.59M | Buy |
18,455
+1,771
| +11% | +$152K | 0.49% | 33 |
|
|
2024
Q3 | $1.99M | Sell |
16,684
-560
| -3% | -$66.7K | 0.61% | 27 |
|
|
2024
Q2 | $2.46M | Buy |
17,244
+866
| +5% | +$124K | 0.78% | 22 |
|
|
2024
Q1 | $2.1M | Buy |
16,378
+488
| +3% | +$62.7K | 0.71% | 22 |
|
|
2023
Q4 | $1.64M | Buy |
15,890
+3,478
| +28% | +$360K | 0.61% | 25 |
|
|
2023
Q3 | $1.13M | Buy |
12,412
+7,168
| +137% | +$652K | 0.45% | 31 |
|
|
2023
Q2 | $424K | Buy |
5,244
+1,842
| +54% | +$149K | 0.16% | 69 |
|
|
2023
Q1 | $271K | Buy |
+3,402
| New | +$271K | 0.11% | 92 |
|